- Bierman, P.J., Vose, J.M., Anderson, J.R., Bishop, M.R., Kessinger, A. and Armitage, J.O. (1997) High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin‘s lymphoma, J. Clin. Oncol. 15, 445–450.
- Fouillard, L., Laporte, J.P., Labopin, M., Lesage, S., Isnard, F.,Douay, L., Lopez, M., Aoudjhane, M., Zunic, P., Cheron, N., Stachowiak, J., Lemonnier, M.P., Andreu, G., Belkacemi, Y., Noel-Walter, M.P., Morel, P., Fenaux, P., Jouet, J.P., Bauters, F., Najman, A. and Gorin, N.C. (1998) Autologous stem-cell transplantation for non-Hodgkin‘s lymphomas: the role of graft purging and radiotherapy post-transplantation-results of a retrospective analysis on 120 patients autograftet in a single institution, J. Clin. Oncol. 16, 2803–2816.
- Freedmann, A.S., Ritz, J., Neuberg, D., Anderson, K.C., Rabinowe, S.N., Mauch, P., Takvorian, T., Soiffer, R., Blake, K., Yeap, B., et al. (1991) Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin‘s lymphoma, Blood 77, 2524–2529.
- Haas, R., Moos, M., Karcher, A., Mohle, R.,Witt, B., Goldschmidt, H., Fruhauf, S., Flentje, M., Wannenmacher, M. and Hunstein, W. (1994) Sequential high dose therapy with peripheral blood progenitor-cell support in low-grade non-Hodgkin‘s lymphoma, J. Clin. Oncol. 12, 1685–1692.
- Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., et al. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin‘s lymphoma, N. Engl. J. Med. 333, 1540–1545.
- Williams, C.D., Goldstone, A.H., Pearce, R.M., Philip, T., Hartmann, O., Colombat, P., Santini, G., Fouillard, L. and Gorin, N.C. (1996) Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin‘s lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma registry, J. Clin. Oncol. 14, 2454–2464.
- Young, R.C., Longo, D.L., Glatstein, E., Ihde, D.C., Jaffe, E.S. and De Vita, Jr., V.T. (1988) The treatment of indolent lymphomas: watchful waiting vs aggressive combined modality treatment, Sem. Hematol. 25, 11–16.
- Blystad, A., Kvalheim, G., Torlakovic, E., Holte, H., Jacobson, E., Beiske, K., Valerhaugen, H., Lenschow, E. and Kvaloy, S. (1999) High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non–Hodgkin‘s lymphoma, Bone Marrow Transplant. 24, 865–872.
- Jacquy, C., Lambert, F., Soree, A., Van Daele, S., Heusterspreute, M., Bosly, A., Ferrant, A., Parma, J., Bron, D. and Martiat, P. (1999) Peripheral blood stem cell contamination in mantle cell non-Hodgkin‘s lymphoma: the case for purging?, Bone Marrow Transplant. 23, 681–686.
- Schouten, H.C., Kvaloy, S., Sydes, M., Qian, W. and Fayers, P.M. (2000) The CUP trial: a randomized study analyzing the efficacy of high-dose therapy and purging in low-grade non–Hodgkin‘s lymphoma, Ann. Oncol. 11(1), 91–94.
Leukemia & Lymphoma
Volume 43, 2002 - Issue 2